Ann Arbor, MI, United States of America

Kevin Carbajal

This inventor holds 1 USPTO granted patent. Top assignee: University of Michigan. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kevin Carbajal. Retrieved from https://idiyas.com/inventor/kevin-carbajal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kevin Carbajal: Innovator in Neurological Disorder Treatments

Introduction

Kevin Carbajal is an accomplished inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of neuroscience, particularly in the treatment of neurological disorders. His innovative work focuses on the development of compositions and methods that utilize neutrophils to rescue damaged neurons.

Latest Patents

Kevin Carbajal holds a patent for "Compositions and methods for treating neurological disorders." This patent outlines compositions and methods that specifically target neurological disorders. The invention details how neutrophils can be used to rescue damaged neurons, along with methods for creating these neutrophils and promoting their generation in vivo. He has 1 patent to his name.

Career Highlights

Kevin Carbajal is affiliated with the University of Michigan, where he conducts his research and development work. His role at this prestigious institution allows him to collaborate with leading experts in the field and contribute to groundbreaking advancements in neurological treatments.

Collaborations

Some of his notable coworkers include Benjamin M. Segal and Andrew Sas. Their collaborative efforts enhance the research environment and foster innovation in the treatment of neurological disorders.

Conclusion

Kevin Carbajal's work represents a significant advancement in the treatment of neurological disorders, showcasing the potential of neutrophils in medical applications. His contributions to the field are invaluable and highlight the importance of innovative research in improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…